Tiglipza
Brand Name: Tiglipza
Generic Name: Sitagliptin (as phosphate)
Active
Registration Number
DRP-13646-02
Dosage Form
Film-Coated Tablet
Issuance Date
March 1, 2024
Expiry Date
March 22, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 mg
PackagingAlu/Alu Blister Pack x 10's / (Box of 30 Tablets)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Sitagliptin (as phosphate)Active
Monograph: Sitagliptin Tartrate